As shown in Figure 1C, GFPT1 protein levels were elevated in breast cancer, colon cancer, ovarian cancer, clear cell RCC, uterine corpus endometrial carcinoma, lung cancer, glioblastoma, and liver cancer tissues compared to normal tissues. This evidence concerns the gene GFPT1 and uterine corpus endometrial carcinoma.